Abcuro Highlights Phase 2/3 MUSCLE Study Results of Ulviprubart in Inclusion Body Myositis at GCOM 2026 Abcuro, Inc. has announced new clinical data from its Phase 2/3 MUSCLE study evaluating…
Drug Farm Secures U.S. FDA Orphan Drug Designation for DF-003 in Treating ROSAH Syndrome Drug Farm has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug…
Nordic Cold Chain Solutions Unveils Innovation Lab Focused on GLP-1 and Small-Format Packaging Solutions Nordic Cold Chain Solutions has announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab,…
Invivoscribe Expands IVDR Portfolio with Certification of IdentiClone Dx IGH Assay Invivoscribe, a globally recognized leader in precision diagnostics and measurable residual disease (MRD) testing, has announced a major regulatory…
Aledade Partners Demonstrate Superior Hypertension Control, Surpassing Large Health Systems in New Case Study Aledade, a physician-led organization recognized as a national leader in advancing value-based care, has released the…
Alpha Cognition Inc. Announces Fiscal 2025 Financial Results and Operational Progress Update Alpha Cognition Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for neurodegenerative disorders, has reported its…
Agenus to Host March 2026 Stakeholder Webcast Highlighting Progress of BOT + BAL Immunotherapy and Expanding Patient Access Across Multiple Tumor Types Agenus Inc., a biotechnology company focused on advancing…
Biocytogen Announces U.S. Food and Drug Administration IND Clearance for Partner NEOK Bio’s NEOK002 in Solid Tumor Indications Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has announced a significant regulatory milestone achieved…
Long Bridge Medical Secures U.S. Food and Drug Administration Clearance to Launch Pivotal U.S. Study of LensOne Prosthetic Capsular Bag Long Bridge Medical, Inc. has reached an important regulatory milestone…
Bio-Techne Expands Spatial Biology Capabilities with Modular Enhancement of the COMET™ Suite Bio-Techne Corporation has announced a significant expansion of its spatial biology capabilities with the introduction of new tools…
WuXi Biologics Announces Record 2025 Annual Results, Fueled by Operational Excellence and Digital-Native Infrastructure WuXi Biologics has reported strong financial and operational performance for 2025, marking a year of significant…
Pet Partners and Baxter Foundation Expand Therapy Animal Programs to Reach 100,000 Patients and Healthcare Workers in Two-Year Pilot Pet Partners and the Baxter Foundation, the charitable arm of Baxter…